The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial

BACKGROUND: We hypothesise, based upon the findings from our previous trial, that the addition of co-trimoxazole to standard therapy is beneficial to patients with moderate to severe idiopathic pulmonary fibrosis (IPF). We aim to investigate this by assessing unplanned hospitalisation-free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammond, Matthew, Clark, Allan B., Cahn, Anthony P., Chilvers, Edwin R., Fraser, William Duncan, Livermore, David M., Maher, Toby M., Parfrey, Helen, Swart, Ann Marie, Stirling, Susan, Thickett, David, Whyte, Moira, Wilson, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800095/
https://www.ncbi.nlm.nih.gov/pubmed/29402332
http://dx.doi.org/10.1186/s13063-018-2453-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800095/
https://www.ncbi.nlm.nih.gov/pubmed/29402332
http://dx.doi.org/10.1186/s13063-018-2453-6

Ejemplares similares